• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in avian influenza A(H7N9) infection Patients

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2025 Jun 17:107957.
doi: 10.1016/j.ijid.2025.107957. Online ahead of print. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in avian influenza A(H7N9) infection Patients

Yuefeng Wang[SUP] 1 [/SUP], Jili Ni[SUP] 2 [/SUP], Mingzhu Huang[SUP] 2 [/SUP], Wenxin Qu[SUP] 2 [/SUP], Chang Liu[SUP] 2 [/SUP], Zheying Mao[SUP] 2 [/SUP], Jiaqi Bao[SUP] 3 [/SUP], Weizhen Chen[SUP] 3 [/SUP], Dongsheng Han[SUP] 3 [/SUP], Fei Yu[SUP] 3 [/SUP], Yifei Shen[SUP] 3 [/SUP], Zhenzhen Deng[SUP] 4 [/SUP], Shufa Zheng[SUP] 5 [/SUP]



Affiliations
Abstract

Objectives: Avian influenza such as H7N9 is currently a major global public health risk, and at present, there is a lack of relevant diagnostic and treatment markers.
Methods: We collected plasma samples from 104 confirmed H7N9 patients, 31 of whom died. Plasma metabolites were detected by UHPLC-HRMS, and a survival prediction model based on metabolites was constructed by machine learning models.
Results: A total of 1536 metabolites were identified in the plasma samples of H7N9 patients, of which 64 metabolites were up-regulated and 35 metabolites were down-regulated in the death group. The enrichment analysis of Tryptophan metabolism, Porphyrin metabolism and Riboflavin metabolism were significantly up-regulated in the death group. We found that most Lipids and lipid-like molecules were down-regulated in the death group, and Organoheterocyclic compounds were significantly up-regulated in the death group. A machine learning model was constructed for predicting mortality based on Porphobilinogen, 5-Hydroxyindole-3-acetic acid, L-Kynurenine, Biliverdin, and D-Dimer. The AUC on the test set was 0.929.
Conclusions: We first revealed the plasma metabolomic characteristics of H7N9 patients and found that a machine learning model based on plasma metabolites could predict the risk of death for H7N9 in the early stage of admission.

Keywords: H7N9; Metabolomic; Tryptophan metabolism; death prediction model; machine learning.

 
Back
Top